You are here

A REMS for Long-Acting Opioid Analgesics: Anticipated Impact on the Dual Public Health Issues of Non-Medical Use and Patient Pain Care

Aaron M. Gilson

Journal of Pain and Symptom Management, Volume 39, Issue 2, February 2010, p370  


  1. Discuss principal characteristics of the FDA's implemented REMS program.
  2. Discuss how the current REMS program is able to respond to prescription opioid medication abuse and diversion.
  3. Discuss how the current REMS program can influence legitimate prescribing of opioid medications for patient pain relief.

Search form


Subscribe to our E-Alert to keep up to date with the new items in the Resource Centre

What do you think?

Please take a moment to fill out our reader survey.

Read more